4.7 Article

Analysis of U8 snoRNA Variants in Zebrafish Reveals How Bi-allelic Variants Cause Leukoencephalopathy with Calcifications and Cysts

期刊

AMERICAN JOURNAL OF HUMAN GENETICS
卷 106, 期 5, 页码 694-706

出版社

CELL PRESS
DOI: 10.1016/j.ajhg.2020.04.003

关键词

-

资金

  1. Great Ormond Street Hospital Charity [V4017]
  2. National Research Agency (France) under the Investments for the Future program [ANR-10IAHU-01]
  3. MSDAvenir fund (DEVO-DECODE Project)
  4. Stroke Association (TSA LECT) [2017/02]
  5. Belgian Fonds de la Recherche Scientifique (F.R.S./FNRS)
  6. Universite Libre de Bruxelles (ULB)
  7. Region Wallonne (DGO6) [1810070]
  8. Fonds Jean Brachet
  9. International Brachet Stiftung
  10. BBSRC [BB/R014361/1] Funding Source: UKRI

向作者/读者索取更多资源

How mutations in the non-coding U8 snoRNA cause the neurological disorder leukoencephalopathy with calcifications and cysts (LCC) is poorly understood. Here, we report the generation of a mutant U8 animal model for interrogating LCC-associated pathology. Mutant U8 zebrafish exhibit defective central nervous system development, a disturbance of ribosomal RNA (rRNA) biogenesis and tp53 activation, which monitors ribosome biogenesis. Further, we demonstrate that fibroblasts from individuals with LCC are defective in rRNA processing. Human precursor-U8 (pre-U8) containing a 3' extension rescued mutant U8 zebrafish, and this result indicates conserved biological function. Analysis of LCC-associated U8 mutations in zebrafish revealed that one null and one functional allele contribute to LCC. We show that mutations in three nucleotides at the 5' end of pre-U8 alter the processing of the 3' extension, and we identify a previously unknown base-pairing interaction between the 5' end and the 3' extension of human pre-U8. Indeed, LCC-associated mutations in any one of seven nucleotides in the 5' end and 3' extension alter the processing of pre-U8, and these mutations are present on a single allele in almost all individuals with LCC identified to date. Given genetic data indicating that bi-allelic null U8 alleles are likely incompatible with human development, and that LCC is not caused by haploinsufficiency, the identification of hypomorphic misprocessing mutations that mediate viable embryogenesis furthers our understanding of LCC molecular pathology and cerebral vascular homeostasis.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Clinical Neurology

Cerebrospinal fluid neopterin as a biomarker of treatment response to Janus kinase inhibition in Aicardi-Goutieres syndrome

Velda X. Han, Shekeeb S. Mohammad, Hannah F. Jones, Sushil Bandodkar, Yanick J. Crow, Russell C. Dale

Summary: In the treatment of Aicardi-Goutières syndrome (AGS), Janus kinase (JAK) 1 inhibition shows a precision medicine approach targeting type I interferon-mediated cell signaling. Elevated cerebrospinal fluid (CSF) neopterin levels in AGS patients decreased significantly in response to JAK inhibitors, indicating a potential role for CSF neopterin as a biomarker of treatment response.

DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY (2022)

Article Rheumatology

The 2021 EULAR and ACR points to consider for diagnosis and management of autoinflammatory type I interferonopathies: CANDLE/PRAAS, SAVI and AGS

Kader Cetin Gedik, Lovro Lamot, Micol Romano, Erkan Demirkaya, David Piskin, Sofia Torreggiani, Laura A. Adang, Thais Armangue, Kathe Barchus, Devon R. Cordova, Yanick J. Crow, Russell C. Dale, Karen L. Durrant, Despina Eleftheriou, Elisa M. Fazzi, Marco Gattorno, Francesco Gavazzi, Eric P. Hanson, Min Ae Lee-Kirsch, Gina A. Montealegre Sanchez, Benedicte Neven, Simona Orcesi, Seza Ozen, M. Cecilia Poli, Elliot Schumacher, Davide Tonduti, Katsiaryna Uss, Daniel Aletaha, Brian M. Feldman, Adeline Vanderver, Paul A. Brogan, Raphaela Goldbach-Mansky

Summary: A Task Force developed "points to consider" for the diagnosis, treatment, and long-term monitoring of patients with rare immunodysregulatory diseases. These guidelines aim to standardize and improve care for patients with autoinflammatory interferonopathies, CANDLE/PRAAS, SAVI, and AGS.

ANNALS OF THE RHEUMATIC DISEASES (2022)

Article Clinical Neurology

Autosomal dominant ADAR c.3019G>A (p.(G1007R)) variant is an important mimic of hereditary spastic paraplegia and cerebral palsy

Hannah F. Jones, Marion Stoll, Gladys Ho, Dugald O'Neill, Velda X. Han, Simon Paget, Kirsty Stewart, Jennifer Lewis, Kavitha Kothur, Christopher Troedson, Yanick J. Crow, Russell C. Dale, Shekeeb S. Mohammad

Summary: This study reports three cases of spastic paraplegia or cerebral palsy caused by the ADAR c.3019G>A variant, which has incomplete penetrance and can mimic other diseases. A high level of clinical suspicion is required for diagnosis and treatment of this condition, which may be ameliorated by immunomodulatory therapy.

BRAIN & DEVELOPMENT (2022)

Review Pharmacology & Pharmacy

Zebrafish for modeling stroke and their applicability for drug discovery and development

Siobhan Crilly, Emily McMahon, Paul R. Kasher

Summary: Zebrafish disease modeling has the potential to greatly improve the drug development pipeline for stroke. However, further development of the existing zebrafish stroke models and collaboration between zebrafish and stroke researchers are necessary for wider acceptance and incorporation of this system into translational stroke research.

EXPERT OPINION ON DRUG DISCOVERY (2022)

Article Biochemistry & Molecular Biology

Global mapping of RNA homodimers in living cells

Marta M. Gabryelska, Andrew P. Badrock, Jian You Lau, Raymond T. O'Keefe, Yanick J. Crow, Grzegorz Kudla

Summary: RNA homodimerization plays an important role in various physiological processes, but lack of systematic in vivo detection methods has hindered our understanding. In this study, the researchers used CLASH, PARIS, and other RNA proximity ligation methods to detect RNA homodimers transcriptome-wide. They found that RNA:RNA homodimers mediated by direct base-pairing are rare across the human transcriptome, but enriched in specific transcripts. Furthermore, they discovered homodimerization of SARS-CoV-2 and Zika genomes, which may have implications for antiviral therapies.

GENOME RESEARCH (2022)

Article Immunology

Mutations in RNU7-1 Weaken Secondary RNA Structure, Induce MCP-1 and CXCL10 in CSF, and Result in Aicardi-Goutieres Syndrome with Severe End-Organ Involvement

Leslie Naesens, Josephine Nemegeer, Filip Roelens, Lore Vallaeys, Marije Meuwissen, Katrien Janssens, Patrick Verloo, Benson Ogunjimi, Dimitri Hemelsoet, Levi Hoste, Lisa Roels, Marieke De Bruyne, Elfride De Baere, Jo Van Dorpe, Amelie Dendooven, Anne Sieben, Gillian Rice, Tessa Kerre, Rudi Beyaert, Carolina Uggenti, Yanick J. Crow, Simon J. Tavernier, Jonathan Maelfait, Filomeen Haerynck

Summary: This study analyzed the clinical, genetic, and immunological characteristics of 3 patients with uncharacterized AGS. RNU7-1 gene mutations were found to impair the processing of RDH pre-mRNA. A distinct IFN-I signature was observed in peripheral blood, and MCP-1 (CCL2) and CXCL10 were upregulated in cerebrospinal fluid. Histopathological analysis showed thrombotic microangiopathy in kidney tissue. Dysregulated STAT phosphorylation was observed upon cytokine stimulation.

JOURNAL OF CLINICAL IMMUNOLOGY (2022)

Article Immunology

A partial form of inherited human USP18 deficiency underlies infection and inflammation

Marta Martin-Fernandez, Sofija Buta, Tom Le Voyer, Zhi Li, Lasse Toftdal Dynesen, Francoise Vuillier, Lina Franklin, Fatima Ailal, Alice Muglia Amancio, Louise Malle, Conor Gruber, Ibtihal Benhsaien, Jennie Altman, Justin Taft, Caroline Deswarte, Manon Roynard, Alejandro Nieto-Patlan, Kunihiko Moriya, Jeremie Rosain, Nathalie Boddaert, Aziz Bousfiha, Yanick J. Crow, Dragana Jankovic, Alan Sher, Jean-Laurent Casanova, Sandra Pellegrini, Jacinta Bustamante, Dusan Bogunovic

Summary: This study identifies a new USP18 mutation that leads to autoinflammation and mycobacterial disease due to insufficient negative regulation of IFN-I signaling, providing important insights into the underlying mechanism of specific interferonopathy.

JOURNAL OF EXPERIMENTAL MEDICINE (2022)

Review Urology & Nephrology

Type I interferon-related kidney disorders

Lorenzo Lodi, Maria V. Mastrolia, Federica Bello, Giovanni M. Rossi, Maria L. Angelotti, Yanick J. Crow, Paola Romagnani, Augusto Vaglio

Summary: Type I interferon mediates tissue damage in kidney disorders, affecting the function of various renal cell types. These disorders can cause renal dysfunction and share pathological features. Defining the classification, pathogenic mechanisms, and histopathological patterns of IFN-I-related kidney disorders is crucial for diagnosis and treatment.

KIDNEY INTERNATIONAL (2022)

Article Rheumatology

The 2021 European Alliance of Associations for Rheumatology/American College of Rheumatology Points to Consider for Diagnosis and Management of Autoinflammatory Type I Interferonopathies: CANDLE/PRAAS, SAVI, and AGS

Kader Cetin Gedik, Lovro Lamot, Micol Romano, Erkan Demirkaya, David Piskin, Sofia Torreggiani, Laura A. Adang, Thais Armangue, Kathe Barchus, Devon R. Cordova, Yanick J. Crow, Russell C. Dale, Karen L. Durrant, Despina Eleftheriou, Elisa M. Fazzi, Marco Gattorno, Francesco Gavazzi, Eric P. Hanson, Min Ae Lee-Kirsch, Gina A. Montealegre Sanchez, Benedicte Neven, Simona Orcesi, Seza Ozen, M. Cecilia Poli, Elliot Schumacher, Davide Tonduti, Katsiaryna Uss, Daniel Aletaha, Brian M. Feldman, Adeline Vanderver, Paul A. Brogan, Raphaela Goldbach-Mansky

Summary: This study aims to improve the diagnosis, treatment, and long-term monitoring of patients with autoinflammatory interferonopathies, CANDLE/PRAAS, SAVI, and AGS. The research team developed guidelines and considerations to enhance care quality and disease outcomes.

ARTHRITIS & RHEUMATOLOGY (2022)

Article Immunology

DNASE1L3 deficiency, new phenotypes, and evidence for a transient type I IFN signaling

Maud Tusseau, Ema Lovsin, Charlotte Samaille, Remi Pescarmona, Anne-Laure Mathieu, Maria-Cristina Maggio, Velma Selmanovic, Marusa Debeljak, Angelique Dachy, Gregor Novljan, Alexandre Janin, Louis Januel, Jean-Baptiste Gibier, Emilie Chopin, Isabelle Rouvet, David Goncalves, Nicole Fabien, Gillian Rice, Gaetan Lesca, Audrey Labalme, Paola Romagnani, Thierry Walzer, Sebastien Viel, Magali Perret, Yanick J. Crow, Tadej Avcin, Rolando Cimaz, Alexandre Belot

Summary: The interferon signaling in DNASE1L3 deficient patients is transient, unlike the anomalies observed in other diseases. DNASE1L3 deficiencies are associated with a broad phenotype including lupus nephritis and hypocomplementemic urticarial vasculitis.

JOURNAL OF CLINICAL IMMUNOLOGY (2022)

Letter Immunology

Clinical Non-penetrance Associated with Biallelic Mutations in the RNase H2 Complex

Yanick J. Crow

JOURNAL OF CLINICAL IMMUNOLOGY (2023)

Article Immunology

Characterization of a mutant samhd1 zebrafish model implicates dysregulation of cholesterol biosynthesis in Aicardi-Goutieres syndrome

Sarah E. Withers, Charlie F. Rowlands, Victor S. Tapia, Frances Hedley, Ioana-Emilia Mosneag, Siobhan Crilly, Gillian I. Rice, Andrew P. Badrock, Andrew Hayes, Stuart M. Allan, Tracy A. Briggs, Paul R. Kasher

Summary: Aicardi-Goutieres syndrome (AGS) is a genetic encephalopathy characterized by excessive type I interferon (IFN-I) activity and upregulation of IFN-stimulated genes (ISGs). Zebrafish were investigated as an alternative model for studying AGS and a mutant zebrafish line recapitulating AGS5 was generated. The homozygous mutant zebrafish larvae exhibited neurological phenotypes, increased expression of ISGs, brain cell death, microcephaly, and locomotion deficits. Dysregulation of cholesterol biosynthesis was also observed in the zebrafish model and AGS patient whole blood, suggesting a potential role of cholesterol dysregulation in AGS pathophysiology.

FRONTIERS IN IMMUNOLOGY (2023)

Editorial Material Clinical Neurology

Editorial: Innovative models of stroke pathology

Siobhan Crilly, Marietta Zille, Paul R. Kasher, Michel Modo

FRONTIERS IN NEUROLOGY (2023)

Review Immunology

The type I interferonopathies: 10 years on

Yanick J. Crow, Daniel B. Stetson

Summary: The term 'type I interferonopathy' was coined 10 years ago to describe rare genetic diseases caused by aberrant upregulation of type I interferon signaling. Viral nucleic acid detection is crucial for effective immune response, but failure in self versus non-self discrimination can lead to Mendelian inborn errors of immunity characterized by upregulation of type I interferon signaling.

NATURE REVIEWS IMMUNOLOGY (2022)

暂无数据